Prophylaxis for recurrent hepatitis B virus infection following liver transplantation

被引：0
作者：
Genda, Takuya [1 ]
机构：
[1] Juntendo Univ, Dept Gastroenterol & Hepatol, Shizuoka Hosp, Shizuoka, Japan
来源：
HEPATOLOGY RESEARCH | 2013年 / 43卷 / 01期
关键词：
IMMUNE GLOBULIN; LAMIVUDINE; VACCINE; DISEASE;
D O I：
10.1111/hepr.12011
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：65 / 66
页数：2
相关论文
共 50 条
  • [21] Hepatitis B infection and liver transplantation
    Yoshida, EM
    CANADIAN JOURNAL OF GASTROENTEROLOGY, 1997, 11 (05): : 462 - 468
  • [22] Shorter hepatitis B immunoglobulin administration is not associated to hepatitis B virus recurrence when receiving combined prophylaxis after liver transplantation
    Lens, Sabela
    Garcia-Eliz, Maria
    Fernandez, Inmaculada
    Castells, Lluis
    Bonacci, Martin
    Mas, Antoni
    Crespo, Gonzalo
    Buti, Maria
    Prieto, Martin
    Forns, Xavier
    LIVER INTERNATIONAL, 2018, 38 (11) : 1940 - 1950
  • [23] Hepatitis B Virus and Hepatitis D Virus Recurrence in Patients Undergoing Liver Transplantation for Hepatitis B Virus and Hepatitis B Virus Plus Hepatitis D Virus
    Adil, B.
    Fatih, O.
    Volkan, I.
    Bora, B.
    Veysel, E.
    Koray, K.
    Cemalettin, K.
    Burak, I.
    Sezai, Y.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (06) : 2119 - 2123
  • [24] Clinical Outcomes and Risk Factors of Hepatitis B Virus Recurrence in Patients Who Received Prophylaxis With Entecavir and Hepatitis B Immunoglobulin Following Liver Transplantation
    Kim, Y-K.
    Kim, S. H.
    Lee, S. D.
    Park, S-J.
    TRANSPLANTATION PROCEEDINGS, 2013, 45 (08) : 3052 - 3056
  • [25] Influence of antiviral therapy in the long-term outcome of recurrent hepatitis C virus infection following liver transplantation
    Garcia-Reyne, A.
    Lumbreras, C.
    Fernandez, I.
    Colina, F.
    Abradelo, M.
    Magan, P.
    San-Juan, R.
    Manrique, A.
    Lopez-Medrano, F.
    Fuertes, A.
    Lizasoain, M.
    Moreno, E.
    Aguado, J. M.
    TRANSPLANT INFECTIOUS DISEASE, 2013, 15 (04) : 405 - 415
  • [26] Liver transplantation in patients with hepatitis B virus, hepatitis C virus, or human immunodeficiency virus
    Duclos-Vallee, Jean-Charles
    Roche, Bruno
    Samuel, Didier
    PRESSE MEDICALE, 2009, 38 (09): : 1281 - 1289
  • [27] Intramuscular hepatitis B immunoglobulin (HBIG) and nucleosides for prevention of recurrent hepatitis B following liver transplantation: comparison with other HBIG regimens
    Anderson, Robert D.
    Chinnakotla, Srinath
    Guo, Linsheng
    Perrillo, Robert P.
    Klintmalm, Goeran B.
    Davis, Gary L.
    CLINICAL TRANSPLANTATION, 2007, 21 (04) : 510 - 517
  • [28] Hepatitis B immunoglobulin prophylaxis for de novo hepatitis B infection in liver transplantation: a 30-year experience
    Jung, Hye-Sol
    Choi, Youngrok
    Yoon, Kyung Chul
    Hong, Su Young
    Suh, Sanggyun
    Hong, Kwangpyo
    Han, Eui Soo
    Lee, Jeong-Moo
    Hong, Suk Kyun
    Yi, Nam-Joon
    Lee, Kwang-Woong
    Suh, Kyung-Suk
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (05)
  • [29] Recommendations for Hepatitis B Immunoglobulin and Antiviral Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation
    Akarsu, Mesut
    Onem, Soner
    Turan, Ilker
    Adali, Gupse
    Akdogan, Meral
    Akyildiz, Murat
    Aladag, Murat
    Balaban, Yasemin
    Danis, Nilay
    Dayangac, Murat
    Gencdal, Genco
    Gokcan, Hale
    Sertesen, Elif
    Gurakar, Merve
    Harputluoglu, Murat
    Kabacam, Gokhan
    Karademir, Sedat
    Kiyici, Murat
    Idilman, Ramazan
    Karasu, Zeki
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2021, 32 (09) : 712 - 719
  • [30] Pharmacokinetics and efficacy of intravenous or intramuscular hepatitis B immunoglobulins in prophylaxis of hepatitis B after liver transplantation
    Marzano, A.
    Marengo, A.
    Andreone, P.
    Volpes, R.
    Canova, D.
    Cursaro, C.
    Riili, A.
    Fiorentino, B.
    Bacci, M.
    Guazzini, S.
    Burra, P.
    MINERVA MEDICA, 2010, 101 (06) : 373 - 383
12345